THE POLICY EDGE
Policy Bites

21 November 2026

Biotechnology Research Council Seeks to Turn Shared Research into Products and Bioeconomy Growth

At its fourth annual meeting, the Biotechnology Research and Innovation Council (BRIC) set out how shared research facilities, stronger industry ties and support for young scientists could help turn biotechnology discoveries into products. The effort sits within India’s stated ambition of a US$300 billion bioeconomy by 2030 and US$1 trillion by 2047

Policy Bites image

Key Details

Biotechnology Research and Innovation Council’s (BRIC) annual meeting focused on the institutional and commercial capabilities needed to move research from laboratories into practical use.

  • National ambition: The government aims to expand India’s bioeconomy to US$300 billion by 2030 and US$1 trillion by 2047.

  • Research model: BRIC brings biotechnology institutions together through shared facilities, collaborative programmes and integrated governance, while retaining their individual scientific strengths.

  • Commercialisation: Union Minister Jitendra Singh called for scientists to work with entrepreneurs, investors and industry early in technology development, including through BRIC’s Entrepreneur-in-Residence programme.

  • Institutional changes: BRIC has operationalised its Secretariat and released a handbook consolidating its governance rules. A proposal for the merger of constituent institutions’ existing societies into BRIC was also floated.

  • Talent pipeline: The D.E.S.I.G.N. for BioE3 Challenge has received more than 6,000 proposals from students and citizens across its two categories.


Shared Facilities Are Intended to Connect Research Strengths

BRIC’s model allows constituent institutions to pursue joint work and use shared capabilities across fields. At the meeting, the Council reviewed research in healthcare, agriculture, animal health and sustainable materials — areas where discoveries may have applications for patients, farmers and industry.

The institutional restructuring is still taking shape. Alongside its operational Secretariat, BRIC is considering the merger of existing societies of constituent autonomous institutions into the Council.

The Next Priority Is Moving Discoveries Toward Use

The meeting placed research translation at the centre of BRIC’s agenda. Developing a diagnostic, therapy or agricultural technology requires more than a promising laboratory result: researchers also need funding, testing, regulatory guidance and partners able to develop and produce it at scale. Earlier engagement with industry and investors is intended to strengthen that path.

BRIC also discussed support for young researchers, collaboration across disciplines and ways to connect Indian scientists working abroad with research opportunities at its institutions.


Policy Relevance

BRIC is a test of whether institutional integration can improve the use of public research capacity. Shared facilities and joint programmes may help researchers combine expertise that sits across separate institutions. The more consequential test is whether those collaborations produce technologies that can be developed, approved and used.

Progress toward the national bioeconomy targets will depend on a wider ecosystem than BRIC alone. For the Council, useful measures of progress would include research collaborations that advance into validated products, industry partnerships that sustain development, and technologies adopted in health, agriculture or manufacturing.


Relevant Question for Policy Stakeholders: Which measures will show whether BRIC’s shared research model is moving discoveries beyond publications and patents into products people and industries use?


Follow the Full News Here: BRIC’s Fourth Annual General Meeting

Rethinking Public Policy Through Insight | Inquiry | Impact

Opinion • Grassroots Voices • Policymakers Perspectives • Expert Analysis • Policy Briefs